How Ibogaine Became the Darling of the Psychedelic Right
Texas is leading the charge to turn an African psychedelic into a life-saving drug. But will iboga’s historic stewards get a cut?
Read MoreTrump order could fast-track review of psychedelic ibogaine. What is it?
President Trump signed an executive order Saturday for a speedy review of psychedelic drugs, including ibogaine.
Read MoreTrump signs order fast tracking review of psychedelics for mental health disorders
President endorses psilocybin and ibogaine: “Can I have some, please?”
Read MoreTrump signs order to speed up access to psychedelic drug treatments
Donald Trump has signed an executive order speeding up reviews of psychedelic drugs – including for ibogaine, touted as a possible treatment for post-traumatic stress disorder.
Read MoreTrump joined by Joe Rogan as he signs order to speed up psychedelic review
Order calls on federal government to relax restrictions on psychedelics, including ibogaine, for potential treatments.
Read MoreTrump Signs Executive Order to Expedite Testing of Psychedelics Use to Combat PTSD
After receiving a text from Joe Rogan, who attended the Oval Office order signing, president allows to FDA to research Ibogaine and other formerly “taboo” psychedelics
Read MoreTrump signs order to hasten review of psychedelics
Ibogaine and other psychedelics remain banned under the federal government’s most restrictive category for illegal, high-risk drugs. But the administration is taking steps to ease restrictions and spur research on using the drugs for medical purposes, including conditions like severe depression.
Read MoreWatch: Trump signs executive order easing U.S. restrictions on psychedelic research
President Trump signed an executive order Saturday that eases restrictions on the research of the psychedelics including the drug ibogaine, which is used in some countries to treat post-traumatic stress disorder.
Read MoreTrump announces reforms to accelerate access to psychedelic drug treatments
President signed executive order directing FDA to expedite review of psychedelic drugs including ibogaineDonald Trump on Saturday announced reforms intended to speed up access to medical research and treatment based on psychedelic drugs.The president signed an executive order directing the federal Food and Drug Administration (FDA) to expedite review of drugs such as ibogaine, a…
Read MoreTrump signs order to speed review of psychedelics, including the controversial drug ibogaine
President Donald Trump has directed his administration to speed up reviews of certain psychedelic drugs, including ibogaine
Read More